Laura A. MacDonald - 20 Feb 2026 Form 4 Insider Report for COGNEX CORP (CGNX)

Role
VP and PAO
Signature
Laura A. MacDonald
Issuer symbol
CGNX
Transactions as of
20 Feb 2026
Net transactions value
-$76,649
Form type
4
Filing time
24 Feb 2026, 16:20:07 UTC
Previous filing
19 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MACDONALD LAURA ANN VP and PAO 1 VISION DRIVE, NATICK Laura A. MacDonald 24 Feb 2026 0001773704

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGNX Common Stock Options Exercise $0 +1,902 +48% $0.000000 5,825 20 Feb 2026 Direct
transaction CGNX Common Stock Tax liability $31,321 -559 -9.6% $56.03 5,266 20 Feb 2026 Direct F1
transaction CGNX Common Stock Options Exercise $0 +2,754 +52% $0.000000 8,020 21 Feb 2026 Direct
transaction CGNX Common Stock Tax liability $45,328 -809 -10% $56.03 7,211 21 Feb 2026 Direct F2
holding CGNX Common Stock 20 20 Feb 2026 By Child F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGNX Restricted Stock Unit Options Exercise $0 -2,754 -100% $0.000000 0 21 Feb 2026 Common Stock 2,754 $0.000000 Direct F4, F5
transaction CGNX Restricted Stock Unit Options Exercise $0 -1,902 -38% $0.000000 3,169 20 Feb 2026 Common Stock 1,902 $0.000000 Direct F4, F6
holding CGNX Non-Qualified Stock Option (right to buy) 33,168 20 Feb 2026 Common Stock 33,168 $33.04 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 37,698 20 Feb 2026 Common Stock 37,698 $39.44 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 30,492 20 Feb 2026 Common Stock 30,492 $47.21 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 10,000 20 Feb 2026 Common Stock 10,000 $48.28 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 42,500 20 Feb 2026 Common Stock 42,500 $50.94 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 30,000 20 Feb 2026 Common Stock 30,000 $51.49 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 15,000 20 Feb 2026 Common Stock 15,000 $56.44 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 7,231 20 Feb 2026 Common Stock 7,231 $57.09 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 23,891 20 Feb 2026 Common Stock 23,891 $64.43 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 13,946 20 Feb 2026 Common Stock 13,946 $90.50 Direct
holding CGNX Restricted Stock Unit 982 20 Feb 2026 Common Stock 982 $0.000000 Direct
holding CGNX Restricted Stock Unit 9,685 20 Feb 2026 Common Stock 9,685 $0.000000 Direct
holding CGNX Restricted Stock Unit 11,211 20 Feb 2026 Common Stock 11,211 $0.000000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2026 and are reported herein.
F2 This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2026 and are reported herein.
F3 Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
F4 Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
F5 The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.
F6 The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively.